Developing next generation treatments to preserve vision for patients with diseases affecting the back of the eye

Oxurion NV Announces the Passing of Dr. Claude Sander, Chief Legal Officer and Corporate Secretary to the Board

21 Dec 2019

Leuven, Belgium, December 21st 2019 – It is with profound sadness that the Board, Management and Staff of Oxurion NV (Euronext Brussels: OXUR) share the news that Chief Legal Officer and Corporate Secretary to the Board, Dr Claude Sander, passed suddenly on 20th December 2019.

Patrik De Haes, MD, CEO of Oxurion and Thomas Clay, Chairman of the Board of Oxurion comment: “We are deeply shocked and extremely saddened with the passing of Claude. The thoughts of everyone at Oxurion are with his family and friends, and we would like to extend our deepest sympathies to them.”

 “It was a privilege and pleasure to have known Claude and to have worked with him for almost a decade. Claude always demonstrated exceptional leadership in his role as Chief Legal Officer and more recently as Corporate Secretary to the Board, even in very challenging situations. He was both admired and respected for his relentless commitment, expertise and achievements. Claude made things work, not only for Oxurion as a business but equally for all individual members of the Oxurion family. Claude will be deeply missed and will always have a very special place in our hearts.” 

“On behalf of the Board, Management and all the staff at Oxurion, we would like to pay tribute to his contribution and long-lasting legacy to the Company.”